A retrospective, observational study asseessing the efficacy and safety of salvage therapy using carlzomib for relapsed or refractory multiple myeloma patients.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2016 New trial record